logo
Plus   Neg
Share
Email

Roche Gets CE Mark For Its Accu-Chek SugarView App - Quick Facts

Swiss drug maker Roche Group (RHHBY) announced Tuesday that it has obtained the CE Mark for its Accu-Chek SugarView app, which is designed to help non-insulin-dependent people with type 2 diabetes or pre-diabetes.

The company noted that Accu-Chek SugarView is the first app that determines blood glucose ranges by taking photos with the smartphone camera without the need of a blood glucose meter.

The app is now officially classified as in-vitro diagnostics or IVD software. Roche will make the app widely accessible first for certain smartphone models through the Google Play Store. It will provide broader access to therapy relevant information for non-insulin dependent people with type 2 diabetes or pre-diabetes.

With the mark, the company now could launch its diabetes management solution in Europe and further countries around the world requiring the CE Mark.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration has granted accelerated approval to Tazverik for the treatment of adults and pediatric patients aged 16 years and older with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection. Epithelioid sarcoma is a rare sub-type of soft... STIHL recalls about 16,400 STIHL RE 90 pressure washers due to injury hazard. According to the company, the recalled pressure washer nozzle can disconnect from the spray wand when under pressure during use, posing an injury hazard. STIHL said it received seven reports of the nozzle detaching from... CVS Health Corp. launched 13 new HealthHUB locations in CVS Pharmacy stores across Philadelphia and South New Jersey. The healthcare company said it developed the HealthHUB store format to help people manage chronic conditions more conveniently and affordably. The store also features health and wellness products, clinical services and expertise.
Follow RTT
>